Ral GTPases in tumorigenesis: Emerging from the shadows

Experimental Cell Research

Volumn 319, Issue 15, 2013, Pages 2337-2342

  Kashatus, David F ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Exocyst; RalA; RalB; RalBP1; RalGEF; Ras

Indexed keywords

ACTIN; BECLIN 1; CYCLIN B; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPSIN; EXOCYST; FILAMIN; GUANOSINE TRIPHOSPHATASE; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; RAL A PROTEIN; RAL B PROTEIN; RALBP1 PROTEIN; RAS PROTEIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

BLADDER TUMOR; CANCER INHIBITION; CARCINOGENESIS; CELLULAR DISTRIBUTION; COLORECTAL TUMOR; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLIOBLASTOMA; HUMAN; HUMAN CELL CULTURE; INTRACELLULAR SIGNALING; LUNG NON SMALL CELL CANCER; METASTASIS; NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; TUMOR XENOGRAFT; UBIQUITINATION;

EID: 84883234639     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.06.020     Document Type: Review

References (75)

1. Chardin P., Tavitian A. The ral gene: a new ras related gene isolated by the use of a synthetic probe. EMBO J. 1986, 5:2203-2208.
2. Chardin P., Tavitian A. Coding sequences of human ralA and ralB cDNAs. Nucl. Acids Res. 1989, 17:4380.
3. Neel N.F., Martin T.D., Stratford J.K., Zand T.P., Reiner D.J., Der C.J. The RalGEF-Ral Effector signaling network: the road less traveled for anti-Ras drug discovery. Genet. Cancer 2011, 2:275-287.
4. Shirakawa R., Fukai S., Kawato M., Higashi T., Kondo H., Ikeda T., et al. Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases. J. Biol. Chem. 2009, 284:21580-21588.
5. Shao H., Andres D.A. A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. J. Biol. Chem. 2000, 275:26914-26924.
6. Peterson S.N., Trabalzini L., Brtva T.R., Fischer T., Altschuler D.L., Martelli P., et al. Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1. J. Biol. Chem. 1996, 271:29903-29908.
7. Spaargaren M., Bischoff J.R. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc. Nat. Acad. Sci. U.S.A. 1994, 91:12609-12613.
8. Kikuchi A., Demo S.D., Ye Z.H., Chen Y.W., Williams L.T. ralGDS family members interact with the effector loop of ras p21. Mol. Cell Biol. 1994, 14:7483-7491.
9. Hofer F., Fields S., Schneider C., Martin G.S. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Nat. Acad. Sci. U.S.A. 1994, 91:11089-11093.
10. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 1996, 15:810-816.
11. White M.A., Vale T., Camonis J.H., Schaefer E., Wigler M.H. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 1996, 271:16439-16442.
12. Osborne J.K., Zaganjor E., Cobb M.H. Signal control through Raf: in sickness and in health. Cell Res. 2012, 22:14-22.
13. Chalhoub N., Baker S.J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 2009, 4:127-150.
14. Hamad N.M., Elconin J.H., Karnoub A.E., Bai W., Rich J.N., Abraham R.T., et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 2002, 16:2045-2057.
15. Lim K.-H., Baines A.T., Fiordalisi J.J., Shipitsin M., Feig L.A., Cox A.D., et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell. 2005, 7:533-545.
16. Chien Y., White M.A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 2003, 4:800-806.
17. Oxford G., Owens C.R., Titus B.J., Foreman T.L., Herlevsen M.C., Smith S.C., et al. RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res. 2005, 65:7111-7120.
18. Lim K.-H., O'Hayer K., Adam S.J., Kendall S.D., Campbell P.M., Der C.J., et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 2006, 16:2385-2394.
19. Vigil D., Martin T.D., Williams F., Yeh J.J., Campbell S.L., Der C.J. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms. J. Biol. Chem. 2010, 285:34729-34740.
20. Martin T.D., Samuel J.C., Routh E.D., Der C.J., Yeh J.J. Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res. 2011, 71:206-215.
21. Male H., Patel V., Jacob M.A., Borrego-Diaz E., Wang K., Young D.A., et al. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer. Lung Cancer 2012, 77:252-259.
22. Mishra P.J., Ha L., Rieker J., Sviderskaya E.V., Bennett D.C., Oberst M.D., et al. Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. Oncogene 2010, 29:2449-2456.
23. Zipfel P.A., Brady D.C., Kashatus D.F., Ancrile B.D., Tyler D.S., Counter C.M. Ral activation promotes melanomagenesis. Oncogene 2010, 29:4859-4864.
24. Sowalsky A.G., Alt-Holland A., Shamis Y., Garlick J.A., Feig L.A. RalA suppresses early stages of Ras-induced squamous cell carcinoma progression. Oncogene 2010, 29:45-55.
25. Wang H., Owens C., Chandra N., Conaway M.R., Brautigan D.L., Theodorescu D. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis. Cancer Res. 2010, 70:8760-8769.
26. Smith S.C., Oxford G., Baras A.S., Owens C., Havaleshko D., Brautigan D.L., et al. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin. Cancer Res. 2007, 13:3803-3813.
27. Yin J., Pollock C., Tracy K., Chock M., Martin P., Oberst M., et al. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol. Cell Biol. 2007, 27:7538-7550.
28. Fei J., Li Y., Zhu X., Luo X. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS One 2012, 7:e32834.
29. Osei-Sarfo K., Martello L., Ibrahim S., Pellicer A. The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral. Oncogene 2011, 30:3661-3671.
30. Saito R., Shirakawa R., Nishiyama H., Kobayashi T., Kawato M., Kanno T., et al. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene 2013, 32:894-902.
31. Smith S.C., Baras A.S., Owens C.R., Dancik G., Theodorescu D. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer. Cancer Res. 2012, 72:3480-3491.
32. Shipitsin M., Feig L.A. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol. Cell Biol. 2004, 24:5746-5756.
33. Falsetti S.C., Wang D.-A., Peng H., Carrico D., Cox A.D., Der C.J., et al. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth. Mol. Cell Biol. 2007, 27:8003-8014.
34. Peschard P., McCarthy A., Leblanc-Dominguez V., Yeo M., Guichard S., Stamp G., et al. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis. Curr. Biol. 2012, 22:2063-2068.
35. Sablina A.A., Chen W., Arroyo J.D., Corral L., Hector M., Bulmer S.E., et al. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 2007, 129:969-982.
36. Chien Y., Kim S., Bumeister R., Loo Y.M., Kwon S.W., Johnson C.L., et al. RalB GTPase-mediated activation of the IkappaB family Kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006, 127:157-170.
37. González-García A., Pritchard C.A., Paterson H.F., Mavria G., Stamp G., Marshall C.J. RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 2005, 7:219-226.
38. Kinsella B.T., Erdman R.A., Maltese W.A. Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA. J. Biol. Chem. 1991, 266:9786-9794.
39. Wu J.-C., Chen T.-Y., Yu C.-T.R., Tsai S.-J., Hsu J.-M., Tang M.-J., et al. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J. Biol. Chem. 2005, 280:9013-9022.
40. Lim K.-H., Brady D.C., Kashatus D.F., Ancrile B.B., Der C.J., Cox A.D., et al. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA. Mol. Cell Biol. 2010, 30:508-523.
41. Kashatus D.F., Lim K.-H., Brady D.C., Pershing N.L.K., Cox A.D., Counter C.M. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat. Cell Biol. 2011, 13:1108-1115.
42. Bivona T.G., Quatela S.E., Bodemann B.O., Ahearn I.M., Soskis M.J., Mor A., et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell. 2006, 21:481-493.
43. Neyraud V., Aushev V.N., Hatzoglou A., Meunier B., Cascone I., Camonis J. RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane. J. Biol. Chem. 2012, 287:29397-29405.
44. Jullien-Flores V., Dorseuil O., Romero F., Letourneur F., Saragosti S., Berger R., et al. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem. 1995, 270:22473-22477.
45. Cantor S.B., Urano T., Feig L.A. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell Biol. 1995, 15:4578-4584.
46. Park S.H., Weinberg R.A. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 1995, 11:2349-2355.
47. Yamaguchi A., Urano T., Goi T., Feig L.A. An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1. J. Biol. Chem. 1997, 272:31230-31234.
48. Nakashima S., Morinaka K., Koyama S., Ikeda M., Kishida M., Okawa K., et al. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 1999, 18:3629-3642.
49. Ikeda M., Ishida O., Hinoi T., Kishida S., Kikuchi A. Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral. J. Biol. Chem. 1998, 273:814-821.
50. Jullien-Flores V., Mahé Y., Mirey G., Leprince C., Meunier-Bisceuil B., Sorkin A., et al. RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J. Cell Sci. 2000, 113(Pt 16):2837-2844.
51. Awasthi S., Cheng J., Singhal S.S., Saini M.K., Pandya U., Pikula S., et al. Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 2000, 39:9327-9334.
52. Neel N.F., Rossman K.L., Martin T.D., Hayes T.K., Yeh J.J., Der C.J. The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector. Mol. Cell. Biol. 2012, 32:1374-1386.
53. Leake K., Singhal J., Nagaprashantha L.D., Awasthi S., Singhal S.S. RLIP76 Regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer. PLoS One 2012, 7:e34582.
54. Wu Z., Owens C., Chandra N., Popovic K., Conaway M., Theodorescu D. RalBP1 is necessary for metastasis of human cancer cell lines. Neoplasia 2010, 12:1003-1012.
55. Mollberg N.M., Steinert G., Aigner M., Hamm A., Lin F.-J., Elbers H., et al. Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse. Cancer Biol. Ther. 2012, 13:694-700.
56. Wang Q., Wang J.-Y., Zhang X.-P., Lv Z.-W., Fu D., Lu Y.-C., et al. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Carcinogenesis 2013.
57. Moskalenko S., Henry D.O., Rosse C., Mirey G., Camonis J.H., White M.A. The exocyst is a Ral effector complex. Nat. Cell Biol. 2002, 4:66-72.
58. Sugihara K., Asano S., Tanaka K., Iwamatsu A., Okawa K., Ohta Y. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat. Cell Biol. 2002, 4:73-78.
59. Spiczka K.S., Yeaman C. Ral-regulated interaction between Sec5 and paxillin targets exocyst to focal complexes during cell migration. J. Cell Sci. 2008, 121:2880-2891.
60. Cascone I., Selimoglu R., Ozdemir C., Del Nery E., Yeaman C., White M., et al. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J. 2008, 27:2375-2387.
61. Hazelett C.C., Sheff D., Yeaman C. RalA and RalB differentially regulate development of epithelial tight junctions. Mol. Biol. Cell 2011, 22:4787-4800.
62. Bodemann B.O., Orvedahl A., Cheng T., Ram R.R., Ou Y.-H., Formstecher E., et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011, 144:253-267.
63. Kim M.-J., Woo S.-J., Yoon C.-H., Lee J.-S., An S., Choi Y.-H., et al. Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. J. Biol. Chem. 2011, 286:12924-12932.
64. Guo J.Y., Chen H.-Y., Mathew R., Fan J., Strohecker A.M., Karsli-Uzunbas G., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
65. Kidd A.R., Snider J.L., Martin T.D., Graboski S.F., Der C.J., Cox A.D. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78:205-212.
66. Ohta Y., Suzuki N., Nakamura S., Hartwig J.H., Stossel T.P. The small GTPase RalA targets filamin to induce filopodia. Proc. Nat. Acad. Sci. U.S.A. 1999, 96:2122-2128.
67. Frankel P., Aronheim A., Kavanagh E., Balda M.S., Matter K., Bunney T.D., et al. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J. 2005, 24:54-62.
68. Jiang H., Luo J.Q., Urano T., Frankel P., Lu Z., Foster D.A., et al. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 1995, 378:409-412.
69. Sidhu R.S., Clough R.R., Bhullar R.P. Regulation of phospholipase C-delta1 through direct interactions with the small GTPase Ral and calmodulin. J. Biol. Chem. 2005, 280:21933-21941.
70. Fenwick R.B., Prasannan S., Campbell L.J., Nietlispach D., Evetts K.A., Camonis J., et al. Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding. Biochemistry 2009, 48:2192-2206.
71. Fenwick R.B., Campbell L.J., Rajasekar K., Prasannan S., Nietlispach D., Camonis J., et al. The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction. Structure 2010, 18:985-995.
72. Khosravi-Far R., White M.A., Westwick J.K., Solski P.A., Chrzanowska-Wodnicka M., Van Aelst L., et al. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell Biol. 1996, 16:3923-3933.
73. White M.A., Nicolette C., Minden A., Polverino A., Van Aelst L., Karin M., et al. Multiple Ras functions can contribute to mammalian cell transformation. Cell 1995, 80:533-541.
74. Rossé C., L'Hoste S., Offner N., Picard A., Camonis J. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J. Biol. Chem. 2003, 278:30597-30604.
75. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.